AngioDynamics, Inc. (ANGO)
15.78
+0.03
(+0.19%)
USD |
NASDAQ |
Aug 24, 16:00
15.78
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Total Liabilities (Quarterly) : 96.34M for May 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 96.34M |
| February 28, 2026 | 87.32M |
| November 30, 2025 | 93.35M |
| August 31, 2025 | 86.79M |
| May 31, 2025 | 97.17M |
| February 28, 2025 | 99.54M |
| November 30, 2024 | 104.78M |
| August 31, 2024 | 97.05M |
| May 31, 2024 | 112.08M |
| February 29, 2024 | 106.14M |
| November 30, 2023 | 98.40M |
| August 31, 2023 | 66.14M |
| May 31, 2023 | 154.34M |
| February 28, 2023 | 145.19M |
| November 30, 2022 | 150.25M |
| August 31, 2022 | 143.61M |
| May 31, 2022 | 128.26M |
| February 28, 2022 | 113.49M |
| November 30, 2021 | 121.74M |
| August 31, 2021 | 119.81M |
| May 31, 2021 | 121.98M |
| February 28, 2021 | 127.31M |
| November 30, 2020 | 134.18M |
| August 31, 2020 | 128.70M |
| May 31, 2020 | 139.34M |
| Date | Value |
|---|---|
| February 29, 2020 | 121.49M |
| November 30, 2019 | 111.07M |
| August 31, 2019 | 76.29M |
| May 31, 2019 | 221.62M |
| February 28, 2019 | 223.72M |
| November 30, 2018 | 234.40M |
| August 31, 2018 | 148.98M |
| May 31, 2018 | 162.88M |
| February 28, 2018 | 160.10M |
| November 30, 2017 | 176.59M |
| August 31, 2017 | 182.46M |
| May 31, 2017 | 192.93M |
| February 28, 2017 | 172.57M |
| November 30, 2016 | 188.82M |
| August 31, 2016 | 213.99M |
| May 31, 2016 | 218.97M |
| February 29, 2016 | 202.77M |
| November 30, 2015 | 212.73M |
| August 31, 2015 | 224.67M |
| May 31, 2015 | 228.60M |
| February 28, 2015 | 239.38M |
| November 30, 2014 | 255.76M |
| August 31, 2014 | 256.43M |
| May 31, 2014 | 262.06M |
| February 28, 2014 | 254.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 20.04B |
| Penumbra, Inc. | 443.96M |
| Abbott Laboratories | 57.45B |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.16M |
| Shareholders Equity (Quarterly) | 170.82M |
| Debt to Equity Ratio | 0.0641 |
| Current Ratio | 2.183 |
| Net Debt Paydown Yield | -0.27% |